Filing Details
- Accession Number:
- 0001127602-15-024813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-12 18:46:24
- Reporting Period:
- 2015-08-10
- Filing Date:
- 2015-08-12
- Accepted Time:
- 2015-08-12 18:46:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1252004 | S Robert Epstein | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-10 | 2,000 | $51.17 | 9,935 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-08-10 | 2,000 | $212.09 | 7,935 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-08-10 | 2,000 | $0.00 | 2,000 | $51.17 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,000 | 2013-11-26 | 2022-11-26 | No | 4 | M | Direct |
Footnotes
- Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
- The sale was made pursuant to a 10b5-1 plan.
- Grant vests over four years with 25% vesting on the anniversary of the grant date and the remaining portion vesting monthly, subject to optionee's continuing to be a service provider on such date.